Intralink Spine
Intralink-Spine, Inc. Announces ISO-13485 Certification
The certification process included an on-site audit of ILS’s newly constructed GMP manufacturing facility in Lexington, KY.
Intralink Spine
Intralink-Spine Expands Clinical Studies in Australia
The company reports the Réjuve treatment has the potential to fill the gap between non-operative treatments and surgery.
Intralink Spine
Intralink-Spine, Inc. Announces Initiation of Clinical Trials in Australia for their Patented Device Réjuve™
3/5/19: According to Hawkins, “We believe the Réjuve medical device, which structurally reinforces the native intervertebral disc itself, is going to be a better treatment option for many patients with low back pain.
Intralink Spine
Intralink-Spine Expands Clinical Studies To Multiple Sites and Locations
3/27/18: Company has restructured for growth and to better position themselves for a successful CE submission.
Intralink Spine
New Data for Intralink-Spine’s Réjuve Treatment for Low Back Pain
“We’ve demonstrated the safety of this device, and it has performed as expected. The dramatic pain reduction...
